---
figid: PMC5772929__ol-15-01-0683-g00
figtitle: Mechanism through which metformin exerts its antitumor effects (A) by reducing
  the level of insulin in serum to inhibit the PI3K/Akt/mTOR signaling pathway and
  (B) by activating AMPK to inhibit the mTOR pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Nicotiana tabacum
pmcid: PMC5772929
filename: ol-15-01-0683-g00.jpg
figlink: /pmc/articles/PMC5772929/figure/f1-ol-0-0-7412/
number: F1
caption: Mechanism through which metformin exerts its antitumor effects (A) by reducing
  the level of insulin in serum to inhibit the PI3K/Akt/mTOR signaling pathway and
  (B) by activating AMPK to inhibit the mTOR pathway. P13K, phosphoinositide 3-kinase;
  mTOR, mechanistic target of rapamycin; AMPK, AMP-activated protein kinase; met,
  metformin; elF-4E, eukaryotic translation initiation factor 4E; LKB1, liver kinase
  B1; TSC1/2, tuberous sclerosis proteins 1 and 2 complex; IGF1, insulin-like growth
  factor 1; IGF1R, IGF1 receptor; 4EBP1, elF-4E-binding protein 1; S6K, ribosomal
  protein S6 kinase.
papertitle: 'Metformin and cancer: An existing drug for cancer prevention and therapy.'
reftext: Fuming Zi, et al. Oncol Lett. 2018 Jan;15(1):683-690.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9679409
figid_alias: PMC5772929__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC5772929__F1
ndex: e4dbaaee-decb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5772929__ol-15-01-0683-g00.html
  '@type': Dataset
  description: Mechanism through which metformin exerts its antitumor effects (A)
    by reducing the level of insulin in serum to inhibit the PI3K/Akt/mTOR signaling
    pathway and (B) by activating AMPK to inhibit the mTOR pathway. P13K, phosphoinositide
    3-kinase; mTOR, mechanistic target of rapamycin; AMPK, AMP-activated protein kinase;
    met, metformin; elF-4E, eukaryotic translation initiation factor 4E; LKB1, liver
    kinase B1; TSC1/2, tuberous sclerosis proteins 1 and 2 complex; IGF1, insulin-like
    growth factor 1; IGF1R, IGF1 receptor; 4EBP1, elF-4E-binding protein 1; S6K, ribosomal
    protein S6 kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ao
  - Gnao1
  - .na.character
  - Tsc2
  - Tsc1
  - Stk11
  - Pik3r1
  - Igf1
  - Rheb
  - Akt1
  - Mlst8
  - Mtor
  - Bad
  - Casp9
  - Rptor
  - Rps6kb1
  - Eif4ebp1
  - Eif4e
  - Ccnd1
  - Pik3cg
  - Prkaa2
  - Ccne1
  - IGF1R
  - TSC2
  - TSC1
  - CCL26
  - STK11
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IGF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - MLST8
  - MTOR
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - BAD
  - RPS6KB1
  - EIF4EBP1
  - EIF4E
  - CCND1
  - Met
---
